Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine for Hemodynamic Stress in Laryngoscopy
NCT06103721Phase 4Recruiting
- Start
- Nov 2023
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in hemodynamic instability (2 arms). Primary endpoints: Heart Rate and Blood Pressure. Started Nov 2023; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
hemodynamic instability
Beyond the preview
Go deeper on NCT06103721.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06103721.